AI Built This App. It Made $50K in 7 Weeks.

Cedric, a college student, had no prior iOS coding experience, yet he transformed a niche biohacking trend into a revenue-generating app. He identified a specific, growing interest in tracking peptides and GLP-1s, then built PepAI to meet that demand. This isn't a story about deep technical skill, but about sharp market insight and leveraging modern tools to deliver.

PepAI’s growth was nothing short of explosive. Within just seven weeks of its launch, the app pulled in $50,000 in total revenue. It quickly scaled to an impressive $11,000 in Monthly Recurring Revenue (MRR), attracting almost two thousand active subscriptions. These rapid returns prove the app found its audience and delivered immediate value, turning a niche idea into real income.

Cedric’s strategy hinged on identifying and rapidly capitalizing on a specific, trending niche. He ensured product-market fit from day one by targeting peptide and GLP-1 tracking. Crucially, he built the app in a mere two weeks using Replit for "vibe coding" and treating Claude as his "senior developer." Claude guided him through setting up complex features like RevenueCat for in-app subscriptions ($45/year or $10/month with a three-day trial) and Resend for email services, with Firebase managing the backend data. This AI-powered approach allowed a non-coder to bypass traditional development hurdles and quickly launch a profitable product.

Cedric, a college student, built PepAI in just two weeks with no prior iOS coding experience. That's a staggering feat for anyone, let alone someone without a coding background. His secret weapon was an AI-first development stack, pairing Replit as a flexible coding environment with Claude acting as his personal "senior developer."

Claude handled the heavy lifting, stepping in precisely where Cedric's knowledge gaps appeared. It guided him through configuring the entire Firebase backend for user data management, a crucial component for any modern app. Claude also integrated RevenueCat for in-app subscriptions, which now generate $11K MRR from almost two thousand active users at $45/year or $10/month with a three-day trial.

Beyond subscriptions, Claude also helped set up Resend for all transactional emails, a detail often overlooked but vital for user communication. This demonstrates how large language models are fundamentally democratizing software development. Non-technical founders can now build and launch sophisticated applications like PepAI, previously requiring a team of experienced engineers, at unprecedented speeds.

Cedric’s biggest hurdle wasn't the build, despite zero prior iOS coding experience. Instead, Apple’s App Store proved the real gatekeeper. PepAI faced repeated rejections, often "a million times" according to Cedric, because Apple deemed its features too close to providing medical advice. This stringent stance is common for health and wellness applications.

Apple's review process is notoriously tough, especially when apps touch sensitive user data or health claims. PepAI, designed to track peptides and GLP-1s for safety, inventory, and wellness data, initially triggered these warnings. The platform's rules prioritize user protection, but they create a complex maze for developers.

To overcome this, Cedric diligently researched how other successful apps in the biohacking space positioned themselves. He then carefully modified PepAI’s language and features, ensuring compliance without sacrificing core functionality. This tactical re-framing led to Apple's approval, proving that strategic positioning is crucial.

This experience underscores the high stakes of navigating App Store policies for any health-related technology. Even an AI-powered app built rapidly with tools like Claude and Replit: The AI-powered developer platform must still contend with human-driven regulatory scrutiny. Founders in this space must prioritize compliance as much as innovation to successfully reach their user base.

Cedric skipped traditional ad buys, instead opting for a shrewd, bootstrapped marketing strategy that directly targeted his user base. He meticulously identified and engaged niche Instagram influencers already popular within the biohacking community, where PepAI found its natural home. This direct, personalized outreach bypassed expensive, broad advertising campaigns, proving exceptionally efficient for a new app.

The return on investment was staggering, validating his focused approach. A single influencer post alone drove over $10,000 in attributable revenue, a significant portion of PepAI's impressive $50,000 total in just seven weeks. This success demonstrated the immense power of reaching the right audience with surgical precision, proving far more effective than casting a wide, untargeted net.

Ultimately, Cedric's journey underscores a crucial entrepreneurial truth often overlooked by founders fixated on perfection: in a rapidly evolving market, aggressive and targeted distribution frequently trumps a flawless, albeit delayed, product. Getting your solution into the hands of eager early adopters quickly, even if it means iterating on the product later, can be the defining factor for initial success. He proved that finding your audience is not just half the battle — it’s often the winning move.

What is PepAI?

PepAI is an AI-powered mobile app built by a college student to help users track peptides, GLP-1s, and other wellness data like nutrition, hydration, and symptoms, with integration into Apple Health.

What tech stack was used to build PepAI?

The founder, Cedric, used Replit for coding, Claude as an AI 'senior developer,' Firebase for the backend and user data, RevenueCat for in-app subscriptions, and Resend for emails.

How did a non-coder build an app in two weeks?

He used a method called 'vibe coding' in Replit and relied heavily on the AI assistant Claude to write code, explain complex setups, and guide him through integrating services like Firebase and RevenueCat.

What was the biggest challenge in launching PepAI?

The biggest challenge was getting the app approved by Apple. It was repeatedly rejected because its features were perceived as providing medical advice, which violates App Store guidelines.